Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
quetiapin "neuraxpharm" 25 mg filmovertrukne tabletter
neuraxpharm bohemia s.r.o. - quetiapin fumarat - filmovertrukne tabletter - 25 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "neuraxpharm" 0,18 mg tabletter
neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "neuraxpharm" 0,35 mg tabletter
neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "neuraxpharm" 0,7 mg tabletter
neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "neuraxpharm" 1,1 mg tabletter
neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 1,1 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "neuraxpharm" 0,088 mg tabletter
neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,088 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
quetiapin "neuraxpharm" 100 mg filmovertrukne tabletter
neuraxpharm bohemia s.r.o. - quetiapin fumarat - filmovertrukne tabletter - 100 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
quetiapin "neuraxpharm" 200 mg filmovertrukne tabletter
neuraxpharm bohemia s.r.o. - quetiapin fumarat - filmovertrukne tabletter - 200 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
briumvi
neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.